Centre d'oncologie de Gentilly — Nancy

Public research footprint of Centre d'oncologie de Gentilly, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Ovarian Cancer · Breast Cancer · Metastatic Castration Resistant Prostate Cancer · Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT05901649 — A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)… (Completed)
NCT06170788 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab… (Recruiting)
NCT07227402 — A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre d'oncologie de Gentilly?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.